Drug Design Defect Litigation Faces Its Demise
"The Demise of Drug Design Litigation: Death by Federal Preemption" is the intriguing title of the latest law review article written by the "Rabbi of Torts," Prof. Aaron Twerski (we're not...To view the full article, register now.
Already a subscriber? Click here to view full article